PARLIAMENTARY WRITTEN QUESTION
Pancreatic Cancer: Diagnosis (8 October 2024)

The Department is supporting the National Health Service in taking steps to improve diagnosis times for pancreatic cancer across England, including for the Ealing Central and Acton constituency. The Government is committed to meeting all three NHS cancer waiting time standards across England within the next five years. Meeting these will ensure no patient waits longer than they should for diagnosis or treatment.

We know that pancreatic cancer is difficult to diagnose due to the non-specific nature of its symptoms. NHS England is implementing non-specific symptom pathways for patients who have symptoms, such as unexplained weight-loss and fatigue, that do not align to a single tumour type, and pancreatic cancer is one of the most common cancer types diagnosed through these pathways. NHS England is also providing a route into pancreatic cancer surveillance for those patients at inherited high-risk, to identify lesions before they develop into cancer, as well as increasing general practice direct access to diagnostic tests.

In March 2024, NHS England published guidance for providers and systems to implement a timed Hepato-Pancreato-Biliary cancer pathway with the aim to ensure patients receive a diagnosis or that cancer is ruled out within 28 days of urgent referral. The pathway aims to improve delays in diagnosis, with less time between referral and receiving the outcome of diagnostic tests.